Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

Finding a clinical trial doesn't have to be complicated. Click "start" to begin. 



Additional reading: Why Should You Consider Participating in Diabetes Research?

What's new

Clinical trial currently enrolling for type 2 diabetes – find out if you qualify for this study. Continue Reading »

Novo Nordisk

Plus, a massive $2 billion investment in new production facilities!  Continue Reading »

Intarcia, ITCA-650, type 2 diabetes

Intarcia just announced exciting results for ITCA 650, a small implanted device to treat type 2 diabetes. The tiny device is implanted under the skin just once or twice a year in a quick procedure (within a matter of minutes!) and continuously releases exenatide (a GLP-1 agonist) through a small mini-pump the size of a matchstick... Continue Reading »


The 338-patient, Dexcom-sponsored DIaMonD Study aims to find out. Continue Reading »


Currently recruiting in people newly diagnosed with type 1. Continue Reading »

Xultophy, Novo Nordisk

One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand new phase 3 clinical trial data comparing Xultophy (a GLP-1 agonist/long acting insulin combination taken as a single injection) to Lantus (a long acting insulin) for the treatment of type 2 diabetes. The results of the 26-week study were very impressive... Continue Reading »

Medtronic MiniMed 670G

The clinical trial is testing Medtronic’s 670G “hybrid-closed loop” system (insulin pump + Enlite 3 CGM sensor) in people with type 1 diabetes. Based on the Enlite 3 CGM reading every five minutes, the 670G pump’s software automatically increases/decreases insulin delivery to target a blood glucose of 120 mg/dl... Continue Reading »

Artificial Pancreas trial

Find out if you qualify for this cutting-edge trial. Continue Reading »